PaxMedica Appoints David Hough M.D. as Chief Medical Officer

2 years ago

Announces Additional Management Changes; Independent Directors Now Majority of Board TARRYTOWN, NY, Aug. 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire…

Mustang Bio Announces First Data from Ongoing Multicenter Phase 1/2 Clinical Trial Evaluating MB-106 CAR-T Cell Therapy

2 years ago

Initial data show clinical responses from four of four indolent lymphoma patients, including complete response in follicular lymphoma patient previously…

Comera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing Capabilities

2 years ago

Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous…

RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

2 years ago

BRIDGEWATER, N.J., Aug. 16, 2023 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical…

Bionano Laboratories Receives College of American Pathologists (CAP) Accreditation for its Clinical Laboratory

2 years ago

SAN DIEGO, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories, a laboratory services business of Bionano Genomics, Inc. (Nasdaq: BNGO),…

Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

2 years ago

Transformative Period Led by Acquisition of TeraImmune Company to Prioritize Development of New TI-168 Treg Asset for Hemophilia A Continuing…

Mangoceuticals Launches New Sildenafil Based Erectile Dysfunction Product with Signature Mango Flavor & Rapid Dissolve

2 years ago

Dallas, Texas, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing,…

Jupiter Wellness’ Subsidiary SRM Entertainment, Inc. Announces Pricing of its Initial Public Offering

2 years ago

Jupiter retains 4.5 million shares in SRM Entertainment post-IPO JUPITER, FL, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Jupiter Wellness, Inc. (Nasdaq:…

Health Canada Grants Device License for iCAD’s ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment

2 years ago

NASHUA, N.H., Aug. 16, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer…